Reuters -- AstraZeneca’s top-selling stomach ulcer and acid reflux drug Nexium faces early generic competition in Denmark, where Novartis unit Sandoz launched a cheap copycat version this week.
Reuters -- AstraZeneca’s top-selling stomach ulcer and acid reflux drug Nexium faces early generic competition in Denmark, where Novartis unit Sandoz launched a cheap copycat version this week.
